Ovid Therapeutics
OVID
#9187
Rank
ยฃ56.54 M
Marketcap
ยฃ0.80
Share price
-2.05%
Change (1 day)
-70.52%
Change (1 year)

Revenue for Ovid Therapeutics (OVID)

Revenue in 2024 (TTM): ยฃ0.49 Million

According to Ovid Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ0.5 Million. In 2023 the company made a revenue of ยฃ0.3 Million a decrease over the revenue in the year 2022 that were of ยฃ1.24 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ovid Therapeutics from 2016 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ0.49 M59.81%
2023 ยฃ0.3 M-75.26%
2022 ยฃ1.24 M-99.2%
2021 ยฃ0.15 B1567.76%
2020 ยฃ9.25 M
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA